In this study, B cell surface marker CD19 and CLL-specific surface marker CD5 were used and ZAP70 expressions in the double-positive CD19+CD5+ cells were evaluated; ZAP70 expressions of T cells were easily excluded. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.